Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Gene therapy has emerged as a powerful and very plastic tool to regulate biological functions in diseased tissues with application in virtually all medical fields. An increasing number of experimental and clinical studies underline the importance of genes as curative agents in the future. However, intense research is needed to evaluate the potential of gene therapy to improve efficacy and minimise the toxicity of the procedure.

Original publication

DOI

10.1136/gut.50.1.130

Type

Journal article

Journal

Gut

Publication Date

01/2002

Volume

50

Pages

130 - 135

Addresses

Gene Therapy Unit, Department of Internal Medicine, Clinica Universitaria, Faculty of Medicine, Universidad de Navarra, Pamplona Spain. Volker.Schmitz@uni-bonn.de

Keywords

Humans, Hepatitis, Viral, Human, Liver Neoplasms, Genetic Vectors, Clinical Trials, Phase I as Topic, Clinical Trials, Phase II as Topic, Genetic Therapy